Clinical Trial Detail

NCT ID NCT01483274
Title Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Louisville
Indications

acute myeloid leukemia

Therapies

Decitabine

Age Groups: adult

No variant requirements are available.